BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 35252205)

  • 1. Identification of the Expression Patterns and Potential Prognostic Role of 5-Methylcytosine Regulators in Hepatocellular Carcinoma.
    Liu Y; Zheng S; Wang T; Fang Z; Kong J; Liu J
    Front Cell Dev Biol; 2022; 10():842220. PubMed ID: 35252205
    [No Abstract]   [Full Text] [Related]  

  • 2. 5-Methylcytosine (m5C) Modification Patterns and Tumor Immune Infiltration Characteristics in Clear Cell Renal Cell Carcinoma.
    Chen C; Chen LY; Zhang JX; Xu HG
    Curr Oncol; 2022 Dec; 30(1):559-574. PubMed ID: 36661693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The RNA Methylation Modification 5-Methylcytosine Impacts Immunity Characteristics, Prognosis and Progression of Oral Squamous Cell Carcinoma by Bioinformatics Analysis.
    Gao L; Chen R; Sugimoto M; Mizuta M; Zhou L; Kishimoto Y; Huang X; Omori K
    Front Bioeng Biotechnol; 2021; 9():760724. PubMed ID: 34957065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. m5C regulator-mediated methylation modification phenotypes characterized by distinct tumor microenvironment immune heterogenicity in colorectal cancer.
    Chen Z; Li Q; Lin Y; Lin S; Gao J; Chen S
    Sci Rep; 2023 Jul; 13(1):11950. PubMed ID: 37488178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic and prognostic value of m5C regulatory genes in hepatocellular carcinoma.
    Yang X; Yang F; Lan L; Wen N; Li H; Sun X
    Front Genet; 2022; 13():972043. PubMed ID: 36105093
    [No Abstract]   [Full Text] [Related]  

  • 6. Overview of distinct 5-methylcytosine profiles of messenger RNA in human hepatocellular carcinoma and paired adjacent non-tumor tissues.
    Zhang Q; Zheng Q; Yu X; He Y; Guo W
    J Transl Med; 2020 Jun; 18(1):245. PubMed ID: 32571340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-methylcytosine RNA modification regulators-based patterns and features of immune microenvironment in acute myeloid leukemia.
    Ding Y; Bajpai AK; Wu F; Lu W; Xu L; Mao J; Li Q; Pan Q; Lu L; Wang X
    Aging (Albany NY); 2024 Jan; 16(3):2340-2361. PubMed ID: 38277218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishment of a new molecular subtyping and prognostic signature with m6A/m5C/m1A/m7G regulatory genes for hepatocellular carcinoma.
    Liu T; Wang Y; Li Z; Sun L; Yang K; Chen J; Han X; Qi L; Zhou X; Wang P
    Heliyon; 2023 Nov; 9(11):e21285. PubMed ID: 38027812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-methylcytosine RNA methylation regulators affect prognosis and tumor microenvironment in lung adenocarcinoma.
    Liu T; Hu X; Lin C; Shi X; He Y; Zhang J; Cai K
    Ann Transl Med; 2022 Mar; 10(5):259. PubMed ID: 35402591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. m5C RNA Methylation Regulators Predict Prognosis and Regulate the Immune Microenvironment in Lung Squamous Cell Carcinoma.
    Pan J; Huang Z; Xu Y
    Front Oncol; 2021; 11():657466. PubMed ID: 34195072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. m5C regulator-mediated modification patterns and tumor microenvironment infiltration characterization in colorectal cancer: One step closer to precision medicine.
    Chen B; Xi Y; Zhao J; Hong Y; Tian S; Zhai X; Chen Q; Ren X; Fan L; Xie X; Jiang C
    Front Immunol; 2022; 13():1049435. PubMed ID: 36532062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of N6-Methyladenosine Modification Patterns and Tumor Immune Microenvironment in Pancreatic Adenocarcinoma.
    Liu Y; Li G; Yang Y; Lu Z; Wang T; Wang X; Liu J
    Front Genet; 2021; 12():752025. PubMed ID: 35046996
    [No Abstract]   [Full Text] [Related]  

  • 13. Modification of m5C regulators in sarcoma can guide different immune infiltrations as well as immunotherapy.
    Wu S; Li M; Su R; Shen H; He Y; Zhou Y
    Front Surg; 2022; 9():948371. PubMed ID: 36684288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uncovering the Association Between m
    Gu X; Zhou H; Chu Q; Zheng Q; Wang J; Zhu H
    Front Cell Dev Biol; 2021; 9():727935. PubMed ID: 34589490
    [No Abstract]   [Full Text] [Related]  

  • 15. Distinct 5-methylcytosine profiles of circular RNA in human hepatocellular carcinoma.
    He Y; Zhang Q; Zheng Q; Yu X; Guo W
    Am J Transl Res; 2020; 12(9):5719-5729. PubMed ID: 33042451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of the expression patterns and potential prognostic role of m6A-RNA methylation regulators in Wilms Tumor.
    Jia C; Gao H; Ma W; Liu X; Chang M; Sun F
    BMC Med Genomics; 2023 Sep; 16(1):222. PubMed ID: 37735424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive Analysis of m5C Methylation Regulatory Genes and Tumor Microenvironment in Prostate Cancer.
    Yu G; Bao J; Zhan M; Wang J; Li X; Gu X; Song S; Yang Q; Liu Y; Wang Z; Xu B
    Front Immunol; 2022; 13():914577. PubMed ID: 35757739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptome-Wide 5-Methylcytosine Functional Profiling of Long Non-Coding RNA in Hepatocellular Carcinoma.
    He Y; Shi Q; Zhang Y; Yuan X; Yu Z
    Cancer Manag Res; 2020; 12():6877-6885. PubMed ID: 32801911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. m6A Regulator-Associated Modification Patterns and Immune Infiltration of the Tumor Microenvironment in Hepatocarcinoma.
    Li J; Wang W; Zhou Y; Liu L; Zhang G; Guan K; Cui X; Liu X; Huang M; Cui G; Sun R
    Front Cell Dev Biol; 2021; 9():687756. PubMed ID: 34277630
    [No Abstract]   [Full Text] [Related]  

  • 20. m5C methylation modification guides the prognostic value and immune landscapes in acute myeloid leukemia.
    Liu Y; Chen Y; Cai M; Hong Y; Wu X; Li S
    Aging (Albany NY); 2023 Sep; 15(18):9858-9876. PubMed ID: 37751592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.